# Regeneron Regeneron's Eylea HD and Libtayo gain FDA and EU approvals, respectively, sparking investment and job creation news. Meanwhile, Samsung Bioepis settles with Regeneron for a biosimilar launch, impacting market dynamics. ### About Regeneron Regeneron Pharmaceuticals is a biotechnology company focused on the discovery, development, and commercialization of medicines. ### Insights - regeneron sentiment is up 19.05% from the previous week. - regeneron engagements is up 146.09% from the previous week. ### Engagements: [------] (24h)  [Engagements 24-Hour Time-Series Raw Data](/topic/regeneron/time-series/interactions.tsv) Current Value: [------] Daily Average: [------] [--] Week: [-------] +146% [--] Month: [-------] -96% [--] Months: [----------] +166% [--] Year: [----------] +291% 1-Year High: [----------] on 2026-01-05 1-Year Low: [--] on 2025-09-07 Engagements by network (24h): X: [-----] Reddit: [---] TikTok: [-----] Instagram: [------] News: [--] YouTube: [------] ### Mentions: [---] (24h)  [Mentions 24-Hour Time-Series Raw Data](/topic/regeneron/time-series/posts_active.tsv) Current Value: [---] Daily Average: [---] [--] Week: [---] +1.50% [--] Month: [-----] +3.80% [--] Months: [-----] +39% [--] Year: [-----] +113% 1-Year High: [---] on 2025-12-22 1-Year Low: [--] on 2025-09-07 Mentions by network (24h): X: [---] Reddit: [--] TikTok: [--] Instagram: [--] News: [--] YouTube: [--] ### Creators: [---] (24h)  [Creators 24-Hour Time-Series Raw Data](/topic/regeneron/time-series/contributors_active.tsv) [---] unique social accounts have posts mentioning Regeneron in the last [--] hours which is down 8.80% from [---] in the previous [--] hours Daily Average: [---] [--] Week: [---] -3.10% [--] Month: [---] +8.20% [--] Months: [-----] +22% [--] Year: [-----] +130% 1-Year High: [---] on 2025-05-20 1-Year Low: [--] on 2025-09-07 The most influential creators that mention Regeneron in the last [--] hours | Creator | Rank | Followers | Posts | Engagements | | ------- | ---- | --------- | ----- | ----------- | | [@regeneron](/creator/instagram/regeneron) | [--] | [------] | [--] | [------] | | [@upediashorts](/creator/youtube/upediashorts) | [--] | [----------] | [--] | [------] | | [@nataninvesting](/creator/twitter/nataninvesting) | [--] | [------] | [--] | [-----] | | [@grok](/creator/twitter/grok) | [--] | [---------] | [--] | [---] | | [@societyforscience](/creator/youtube/societyforscience) | [--] | [------] | [--] | [---] | | [@justinskycak](/creator/twitter/justinskycak) | [--] | [------] | [--] | [---] | | [@laasyaacharya](/creator/tiktok/laasyaacharya) | [--] | [---] | [--] | [---] | | [@rishabjaink](/creator/youtube/rishabjaink) | [--] | [------] | [--] | [--] | | [@stellanewslife](/creator/twitter/stellanewslife) | [--] | [-----] | [--] | [--] | | [@tomonota](/creator/reddit/tomonota) | [--] | [------] | [--] | [--] | [View More](/list/creators/regeneron/100) ### Sentiment: 91%  [Sentiment 24-Hour Time-Series Raw Data](/topic/regeneron/time-series/sentiment.tsv) Current Value: 91% Daily Average: 87% [--] Week: 100% +16% [--] Month: 87% +3% [--] Months: 87% +2% [--] Year: 87% -11% 1-Year High: 100% on 2025-02-17 1-Year Low: 22% on 2025-06-14 Most Supportive Themes: - Positive News and Partnerships: (40%) Regeneron's recent FDA approvals for Eylea HD and the expansion of Libtayo in the EU are driving positive sentiment, alongside news of significant investment and job creation in New York. - Innovation and Research: (20%) Mentions of Regeneron's scientific breakthroughs, such as the development of a cost-effective prosthetic arm by a Regeneron Science Talent Search finalist and advancements in genetic medicine, are generating interest. Most Critical Themes: - Market Performance Concerns: (25%) Some discussions touch upon Regeneron's stock fluctuations and past underperformance, though recent news of FDA approvals and investment may be counteracting this. - Negative Sentiment and Criticism: (15%) A smaller portion of posts express negative sentiment, including criticism of the company or its products, though this appears to be outweighed by positive news. ### Top Regeneron Social Posts Top posts by engagements in the last [--] hours *Showing a maximum of [--] top social posts without a LunarCrush subscription.* "Natan YTD: -6.7% S&P500 YTD: -0.1% TOTAL RETURNS (Jan 2022) Natan's portfolio: +108.2% *Benchmark: +36.3% S&P500: +51.8% MY POSITIONS: 18.6% Transmedics $TMDX 15.3% Pinduoduo $PDD 9.1% Alibaba $BABA 7.6% Regeneron $REGN 7.4% Procept BioRobotics $PRCT 7.0% Meta Platforms $META 6.3% Paypal $PYPL 6.3% Robinhood $HOOD 5.7% Wizz Air $WIZZ 5.1% B2gold $BTG 5.0% Moderna $MRNA 3.5% Monday $MNDY 1.8% Edwards Lifesciences $EW 1.3% Crispr Therapeutics $CRSP Follow me: @nataninvesting - - - - - - - - - - - - - - - - - - - * : - 70% - 30% ** . ' and all the ." [X Link](https://x.com/nataninvesting/status/2022669406292045925) [@nataninvesting](/creator/x/nataninvesting) 2026-02-14T13:49Z 39.5K followers, [----] engagements "@regeneron @foxsick @Ker1mđđktđť @mentos71" [TikTok Link](https://www.tiktok.com/@froglo30/video/7606604281705286920) [@froglo30](/creator/tiktok/froglo30) 2026-02-14T06:30Z [--] followers, [---] engagements "High school prodigy #AshkaShah This #JerichoHS senior cracked the Regeneron Science Talent Search finals with groundbreaking cancer research Young minds like hers are our future in beating cancer Inspire the next gen đŞđŹ #CancerResearch #ScienceTalent" [X Link](https://x.com/Subhash_LiveS/status/2022494522840879440) [@Subhash_LiveS](/creator/x/Subhash_LiveS) 2026-02-14T02:14Z [----] followers, [---] engagements "@mvcinvesting [--] months earlier is great but does this licensing agreement means royalties to Regeneron Meaning the margins will now be lower" [X Link](https://x.com/TheRayMyers/status/2022296938784387426) [@TheRayMyers](/creator/x/TheRayMyers) 2026-02-13T13:08Z 21.1K followers, [---] engagements Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
Regeneron's Eylea HD and Libtayo gain FDA and EU approvals, respectively, sparking investment and job creation news. Meanwhile, Samsung Bioepis settles with Regeneron for a biosimilar launch, impacting market dynamics.
Regeneron Pharmaceuticals is a biotechnology company focused on the discovery, development, and commercialization of medicines.
Engagements 24-Hour Time-Series Raw Data
Current Value: [------]
Daily Average: [------]
[--] Week: [-------] +146%
[--] Month: [-------] -96%
[--] Months: [----------] +166%
[--] Year: [----------] +291%
1-Year High: [----------] on 2026-01-05
1-Year Low: [--] on 2025-09-07
Engagements by network (24h): X: [-----] Reddit: [---] TikTok: [-----] Instagram: [------] News: [--] YouTube: [------]
Mentions 24-Hour Time-Series Raw Data
Current Value: [---]
Daily Average: [---]
[--] Week: [---] +1.50%
[--] Month: [-----] +3.80%
[--] Months: [-----] +39%
[--] Year: [-----] +113%
1-Year High: [---] on 2025-12-22
1-Year Low: [--] on 2025-09-07
Mentions by network (24h): X: [---] Reddit: [--] TikTok: [--] Instagram: [--] News: [--] YouTube: [--]
Creators 24-Hour Time-Series Raw Data
[---] unique social accounts have posts mentioning Regeneron in the last [--] hours which is down 8.80% from [---] in the previous [--] hours
Daily Average: [---]
[--] Week: [---] -3.10%
[--] Month: [---] +8.20%
[--] Months: [-----] +22%
[--] Year: [-----] +130%
1-Year High: [---] on 2025-05-20
1-Year Low: [--] on 2025-09-07
The most influential creators that mention Regeneron in the last [--] hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @regeneron | [--] | [------] | [--] | [------] |
| @upediashorts | [--] | [----------] | [--] | [------] |
| @nataninvesting | [--] | [------] | [--] | [-----] |
| @grok | [--] | [---------] | [--] | [---] |
| @societyforscience | [--] | [------] | [--] | [---] |
| @justinskycak | [--] | [------] | [--] | [---] |
| @laasyaacharya | [--] | [---] | [--] | [---] |
| @rishabjaink | [--] | [------] | [--] | [--] |
| @stellanewslife | [--] | [-----] | [--] | [--] |
| @tomonota | [--] | [------] | [--] | [--] |
Sentiment 24-Hour Time-Series Raw Data
Current Value: 91%
Daily Average: 87%
[--] Week: 100% +16%
[--] Month: 87% +3%
[--] Months: 87% +2%
[--] Year: 87% -11%
1-Year High: 100% on 2025-02-17
1-Year Low: 22% on 2025-06-14
Most Supportive Themes:
Most Critical Themes:
Top posts by engagements in the last [--] hours
Showing a maximum of [--] top social posts without a LunarCrush subscription.
"Natan YTD: -6.7% S&P500 YTD: -0.1% TOTAL RETURNS (Jan 2022) Natan's portfolio: +108.2% *Benchmark: +36.3% S&P500: +51.8% MY POSITIONS: 18.6% Transmedics $TMDX 15.3% Pinduoduo $PDD 9.1% Alibaba $BABA 7.6% Regeneron $REGN 7.4% Procept BioRobotics $PRCT 7.0% Meta Platforms $META 6.3% Paypal $PYPL 6.3% Robinhood $HOOD 5.7% Wizz Air $WIZZ 5.1% B2gold $BTG 5.0% Moderna $MRNA 3.5% Monday $MNDY 1.8% Edwards Lifesciences $EW 1.3% Crispr Therapeutics $CRSP Follow me: @nataninvesting - - - - - - - - - - - - - - - - - - - * : - 70% - 30% ** . ' and all the ."
X Link @nataninvesting 2026-02-14T13:49Z 39.5K followers, [----] engagements
"@regeneron @foxsick @Ker1mđđktđť @mentos71"
TikTok Link @froglo30 2026-02-14T06:30Z [--] followers, [---] engagements
"High school prodigy #AshkaShah This #JerichoHS senior cracked the Regeneron Science Talent Search finals with groundbreaking cancer research Young minds like hers are our future in beating cancer Inspire the next gen đŞđŹ #CancerResearch #ScienceTalent"
X Link @Subhash_LiveS 2026-02-14T02:14Z [----] followers, [---] engagements
"@mvcinvesting [--] months earlier is great but does this licensing agreement means royalties to Regeneron Meaning the margins will now be lower"
X Link @TheRayMyers 2026-02-13T13:08Z 21.1K followers, [---] engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
/topic/regeneron